The 21st International Symposium on Pediatric Neuro-Oncology was held June 28-July 2, 2024 in Philadelphia, Pennsylvania. ISPNO is the major global meeting for the international
Over the past 20+ years, work done by clinicians and scientists in the Morgan Adams Foundation Pediatric Brain Tumor Research Program has driven important discoveries
Medulloblastoma is a type of malignant brain tumor that is typically diagnosed in children and adolescents. It is one of the most common brain tumors
As technology continues to advance and researchers learn more about how specific types of cancer form, grow, and respond to treatment, an increasing number of
A child who is diagnosed with cancer has their life turned upside down by appointments, treatments, pain, side effects, hospital stays, and innumerable missed milestones,
Neurofibromatosis Type 1 (NF1) is an inherited genetic disorder that leads to the formation of tumors on the peripheral nervous system, called plexiform neurofibromas. Plexiform
Atypical teratoid/rhabdoid tumor (ATRT) is a rare and highly aggressive pediatric brain tumor. It typically affects kids 3 years and younger. The 5-year overall survival
Brain and spine tumors are one of the most common forms of cancer found in kids, second only to leukemia. Despite significant advances in treatment,
More than a dozen doctors and researchers from the Morgan Adams Foundation Pediatric Brain Tumor Research Program were invited to present their work at the
The 20th International Symposium on Pediatric Neuro-Oncology was held June 13-15, 2022 in Hamburg, Germany. ISPNO is the major global meeting for the international community
